Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

364
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
364
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

89
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
89
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

327
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
327
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

420
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
420
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

124
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic accuracy of <sup>18</sup>F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP).

European journal of nuclear medicine and molecular imaging·2026
Same author

The OMERACT core domain sets for calcium pyrophosphate deposition disease.

Seminars in arthritis and rheumatism·2026
Same author

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update.

Joint bone spine·2026
Same author

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD).

Annals of the rheumatic diseases·2026
Same author

Challenges to Research Integrity in Rheumatology: The Threat of Paper Mills, Fraud, and Click Data Science.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring system.

Annals of the rheumatic diseases·2026
Same journal

Single-Cell Transcriptomics Identifies CD36 as a Negative Regulator of Osteogenic Differentiation in Murine Osteoporosis.

Joint bone spine·2026
Same journal

Infectious pubic symphysitis after prostate cancer treatment: A retrospective case series of 16 patients.

Joint bone spine·2026
Same journal

Answer to Elbaz et al.

Joint bone spine·2026
Same journal

Greater trochanteric bursal distension with intra-bursal rice bodies: an unusual MRI presentation.

Joint bone spine·2026
Same journal

Evaluating the Impact of a Rheumatologist-led Comorbidity Review in Patients with Inflammatory Arthritis.

Joint bone spine·2026
Same journal

What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?

Joint bone spine·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

226

Early-onset gout.

Tristan Pascart1, Vincent Ducoulombier2, Charlotte Jauffret3

  • 1Department of Rheumatology, Saint-Philibert Hospital, Lille Catholic University, Lomme, France; ETHICS Laboratory, EA7446, Lille Catholic University, Lille, France.

Joint Bone Spine
|February 9, 2024
PubMed
Summary
This summary is machine-generated.

Early-onset gout (EOG), appearing before age 40, affects specific ethnic groups and can lead to earlier, more severe joint issues. Early urate-lowering therapy is recommended for managing this condition.

Keywords:
Cardiovascular diseaseEarly-onsetGoutMetabolic syndromePrevalence

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

4.4K

Related Experiment Videos

Last Updated: Jul 4, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

226
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

4.4K

Area of Science:

  • Rheumatology
  • Genetics
  • Epidemiology

Background:

  • Early-onset gout (EOG) is defined as gout symptoms appearing before 40 years of age.
  • EOG disproportionately affects individuals from ethnic groups with strong genetic predispositions, such as Pacific Islanders and Taiwanese populations.
  • Understanding EOG is crucial due to its potential for earlier onset and distinct epidemiological characteristics.

Purpose of the Study:

  • To review the epidemiology of EOG.
  • To describe the clinical presentation, prognosis, and comorbidities associated with EOG.
  • To outline specific management strategies for EOG.

Main Methods:

  • Literature review focusing on epidemiology, clinical features, comorbidities, and management of EOG.
  • Analysis of studies examining genetic factors and ethnic predispositions in gout.
  • Synthesis of current international guidelines regarding EOG treatment.

Main Results:

  • EOG prevalence is highest in populations with genetic predispositions (e.g., Pacific, Taiwan).
  • Clinical presentation and severity are similar to common gout, but longer duration can lead to polyarticular disease.
  • Metabolic comorbidities develop earlier in EOG patients, though less frequent at diagnosis.

Conclusions:

  • EOG has distinct epidemiological patterns linked to genetics.
  • While similar to common gout, EOG may progress to polyarticular disease faster.
  • Early initiation of urate-lowering therapies is advised for EOG management.